Controversial Alzheimer's drug approval could impact other diseases
Nature, Published online: 29 June 2021; doi:10.1038/d41586-021-01763-9
Aducanumab's fast-tracking has researchers both worried and hopeful about the future of drugs for neurodegenerative diseases such as Huntington’s and Parkinson’s.
Comments
Post a Comment